Rhabdomyosarcoma News and Research

RSS
Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Research project receives 25 million U.S. dollars to develop drugs against childhood cancers

Novel assay enhances pediatric cancer treatment by identifying clinically relevant gene fusions

Novel assay enhances pediatric cancer treatment by identifying clinically relevant gene fusions

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

From Cells to Drugs: How Cell Painting is Transforming Drug Discovery

Scientific breakthrough could someday save the lives of children with rhabdomyosarcoma

Scientific breakthrough could someday save the lives of children with rhabdomyosarcoma

Recent advances in the understanding of the role and mechanism of CCAR2 in cancer

Recent advances in the understanding of the role and mechanism of CCAR2 in cancer

Researchers discover potential new treatment for rhabdomyosarcoma

Researchers discover potential new treatment for rhabdomyosarcoma

Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68

Both vaccine strain and adjuvant selection are critical elements for improving the breadth of protective immunity against enterovirus D68

Scientists use enhanced environmental surveillance for poliovirus type 2 detection in London sewage samples

Scientists use enhanced environmental surveillance for poliovirus type 2 detection in London sewage samples

Research identifies unique vulnerabilities in ALT cancers that can serve as novel therapeutic targets

Research identifies unique vulnerabilities in ALT cancers that can serve as novel therapeutic targets

New discovery may open the door to targeted treatments for two types of rhabdomyosarcoma

New discovery may open the door to targeted treatments for two types of rhabdomyosarcoma

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Phase I clinical trial of new blocking antibody therapy shows promising results for the treatment of advanced medulloblastoma

Improving Patient Recruitment for Clinical Trial Research

Improving Patient Recruitment for Clinical Trial Research

Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention

Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention

Research reveals a therapeutic opportunity to prevent  rhabdomyosarcoma recurrence

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

Soy molasses and kudzu roots may help fight against pediatric tumors

Soy molasses and kudzu roots may help fight against pediatric tumors

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

TTUHSC researcher secures $1.9 million grant to investigate vulnerabilities in ALT cancers

Research reveals a possible new treatment approach for pediatric rhabdomyosarcoma

Research reveals a possible new treatment approach for pediatric rhabdomyosarcoma

New findings shed light on genetic changes that underlie rare, aggressive childhood cancer

New findings shed light on genetic changes that underlie rare, aggressive childhood cancer

Study findings help explain the diversity of cancers in different Li-Fraumeni patients

Study findings help explain the diversity of cancers in different Li-Fraumeni patients

MFCR awards new grants to support an emerging approach to cancer therapeutics

MFCR awards new grants to support an emerging approach to cancer therapeutics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.